American Journal of Cardiology
Volume 105, Issue 3 , Pages 283-287 , 1 February 2010

Comparison of 80 versus 10 mg of Atorvastatin on Occurrence of Cardiovascular Events After the First Event (from the Treating to New Targets [TNT] Trial)

  • John C. LaRosa, MD

      Affiliations

    • State University of New York, Health Science Center, Brooklyn, New York
    • Corresponding Author InformationCorresponding author: Tel: 718-270-2611; fax: 718-270-4732
  • ,
  • Prakash C. Deedwania, MD

      Affiliations

    • VA Central California Healthcare System and UCSF School of Medicine, Fresno, California
  • ,
  • James Shepherd, MD

      Affiliations

    • University of Glasgow, Glasgow, United Kingdom
  • ,
  • Nanette K. Wenger, MD

      Affiliations

    • Emory University, Atlanta, Georgia
  • ,
  • Heiner Greten, MD

      Affiliations

    • Hanseatic Heart Center, Asklepios Klinik St. Georg, Hamburg, Germany
  • ,
  • David A. DeMicco, PharmD

      Affiliations

    • Pfizer, Inc., New York, New York
  • ,
  • Andrei Breazna, PhD

      Affiliations

    • Pfizer, Inc., New York, New York
  • ,
  • TNT Investigators

Received 9 June 2009 ,Revised 16 September 2009 ,Accepted 16 September 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 The TNT study was funded by Pfizer, Inc., New York, New York.

PII: S0002-9149(09)02396-0

doi: 10.1016/j.amjcard.2009.09.025

American Journal of Cardiology
Volume 105, Issue 3 , Pages 283-287 , 1 February 2010